Sarepta Plunged After Adverse Event Forces Trial Halt in the UK Post author:Sam Post published:February 11, 2018 Post category:BioPharma But the biotech swiftly indicated that it doesn’t expect the halt to last for long. Source: BioSpace You Might Also Like Finally! STADA Arzneimittel Accepts $5.6 Billion Takeover Offer From Cinven April 9, 2017 Two NIH Sources Reveal is Considering New Cuts to Biomedical Research May 18, 2017 Bay Area's Atara Biotherapeutics Leases Huge Space in SoCal April 19, 2017
